ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Vale Biolabs, a Zurich-based biotech startup, received CHF 150K in funding from Venture Kick on 09/11/2026. The company plans to use the capital to develop its automated platform for AI-driven drug discovery and expand human brain organoid models.
Tap to vote and see what everyone thinks.
Summary by ByteBrief